Provided by Tiger Trade Technology Pte. Ltd.

BioCardia

1.01
+0.04294.44%
Post-market: 1.00-0.0100-0.99%19:31 EDT
Volume:82.46K
Turnover:81.48K
Market Cap:15.03M
PE:-1.37
High:1.02
Open:0.9730
Low:0.9560
Close:0.9671
52wk High:2.29
52wk Low:0.7500
Shares:14.88M
Float Shares:12.27M
Volume Ratio:0.37
T/O Rate:0.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7393
EPS(LYR):-1.2341
ROE:-1803.19%
ROA:-134.97%
PB:5.57
PE(LYR):-0.82

Loading ...

BioCardia Receives Nasdaq Notice on Minimum Bid Price

TIPRANKS
·
Aug 22

BioCardia Receives NASDAQ Notice for Trading Below $1 Minimum Bid Price Requirement

Reuters
·
Aug 22

BioCardia CEO Peter Altman Acquires 5,400 Common Shares Worth $5,022

Reuters
·
Aug 19

Nasdaq Listing Risks: Potential Delisting Threatens Biocardia’s Market Access and Financial Stability

TIPRANKS
·
Aug 14

BioCardia CEO Peter Altman Acquires Common Shares Worth $1,748 in Open Market Purchase

Reuters
·
Aug 14

HeartBeam Q2 Loss Per Share Narrows; Co Lowers FY Net Operating Cash Outflow Guidance

Reuters
·
Aug 14

BioCardia Earnings Call Highlights Regulatory Momentum

TIPRANKS
·
Aug 13

BioCardia Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Sera Prognostics Q2 Revenue Rises on Expanded Partnerships and Medicaid Coverage

Reuters
·
Aug 13

BioCardia Q2 FY26 Net Loss Narrows to $1.61 Million; Cash Rises to $4.12 Million as of June 30, 2026

Reuters
·
Aug 13

BioCardia Q2 EPS $(0.13) Beats $(0.18) Estimate

Benzinga Earnings
·
Aug 13

BioCardia, Inc. Q2 Net Income USD -1.613 Million

Reuters
·
Aug 13

BioCardia, Inc. Q2 Basic EPS USD -0.13

THOMSON REUTERS
·
Aug 13

BioCardia Reports Second Quarter 2026 Business Highlights and Financial Results

THOMSON REUTERS
·
Aug 13

BioCardia Inc Expected to Post a Loss of 18 Cents a Share - Earnings Preview

Reuters
·
Aug 11

BioCardia Inc Expected to Post a Loss of 18 Cents a Share - Earnings Preview

Reuters
·
Aug 07

BioCardia Schedules Q2 Financial Results Conference Call

Reuters
·
Aug 06

BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026

GlobeNewswire
·
Aug 06

BioCardia CEO Peter Altman Acquires 5,000 Common Shares Valued at $3,900

Reuters
·
Jul 30

Biocardia CEO Peter Altman Buys $415 of Common Stock

Reuters
·
Jul 21